Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Fresenius SE & Co. KGaA
DescriptionSynthetic hydroxyethyl starch
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationBlood substitute
Indication DetailsTreat and prevent loss of blood volume
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today